Development and validation of high-throughput glu-curon-idation assays for study of drug-drug interactions

被引：0
|
作者：
Merchant, S [1 ]
Jin, JJ [1 ]
Tai, EHL [1 ]
机构：
[1] Roche Palo Alto, Dept Drug Metab & Pharmacokinet, Palo Alto, CA 94304 USA
来源：
DRUG METABOLISM REVIEWS | 2004年 / 36卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
577
引用
收藏
页码：288 / 288
页数：1
相关论文
共 50 条
  • [21] Unlocking the Potential of High-Throughput Drug Combination Assays Using Acoustic Dispensing
    Chan, Grace Ka Yan
    Wilson, Stacy
    Schmidt, Stephen
    Moffat, John G.
    JALA, 2016, 21 (01): : 125 - 132
  • [22] Design, Development, and Validation of a High-Throughput Drug-Screening Assay for Targeting of Human Leukemia
    Karjalainen, Katja
    Pasqualini, Renata
    Cortes, Jorge E.
    Kornblau, Steven M.
    Lichtiger, Benjamin
    O'Brien, Susan
    Kantarjian, Hagop M.
    Sidman, Richard L.
    Arap, Wadih
    Koivunen, Erkki
    CANCER, 2014, 120 (04) : 589 - 602
  • [23] Development of a Zebrafish Sepsis Model for High-Throughput Drug Discovery
    Anju M. Philip
    Youdong Wang
    Antonio Mauro
    Suzan El-Rass
    John C. Marshall
    Warren L. Lee
    Arthur S. Slutsky
    Claudia C. dos Santos
    Xiao-Yan Wen
    Molecular Medicine, 2017, 23 : 134 - 148
  • [24] High-throughput biopharmaceutical drug development - Meeting the coming challenge
    Nayar, R
    Manning, MC
    BIOPHARM-THE APPLIED TECHNOLOGIES OF BIOPHARMACEUTICAL DEVELOPMENT, 2002, 15 (02): : 20 - +
  • [25] Development of a Zebrafish Sepsis Model for High-Throughput Drug Discovery
    Philip, Anju M.
    Wang, Youdong
    Mauro, Antonio
    El-Rass, Suzan
    Marshall, John C.
    Lee, Warren L.
    Slutsky, Arthur S.
    dos Santos, Claudia C.
    Wen, Xiao-Yan
    MOLECULAR MEDICINE, 2017, 23 : 134 - 148
  • [26] High-Throughput Screening and Drug Development to Fix RyR Pathology
    Rebbeck, Robyn T.
    Rozman, Kaja
    Evans, Gabrielle M.
    Schwarz, Jacob
    Baran, Marzena
    Aldrich, Courtney C.
    Bers, Donald M.
    Thomas, David D.
    Cornea, Razvan L.
    BIOPHYSICAL JOURNAL, 2021, 120 (03) : 148A - 149A
  • [27] High-Throughput process development in rAAV drug substance manufacturing
    Jiang, Y.
    Pesic, M.
    Cueto-Rojas, H. F.
    Mishra, V.
    Demirtas, U.
    Ahamed, T.
    Ljubovic-Couteau, E.
    HUMAN GENE THERAPY, 2024, 35 (3-4) : A147 - A147
  • [28] Physiologically-Based Pharmacokinetic Model Development, Validation, and Application for Prediction of Eliglustat Drug-Drug Interactions
    Sahasrabudhe, Siddhee A.
    Cheng, Shen
    Al-Kofahi, Mahmoud
    Jarnes, Jeanine R.
    Weinreb, Neal J.
    Kartha, Reena, V
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2022, 112 (06) : 1254 - 1263
  • [29] Development of invasion and transendothelial migration assays in 96-well format for use in high-throughput drug discovery
    Kamath, L
    Gregory, JS
    Leonard, MJC
    Phillips, JE
    Sneddon, S
    MOLECULAR BIOLOGY OF THE CELL, 2002, 13 : 77A - 77A
  • [30] High performance affinity chromatography (HPAC) as a high-throughput screening tool in drug discovery to study drug-plasma protein interactions
    Vuignier, Karine
    Guillarme, Davy
    Veuthey, Jean-Luc
    Carrupt, Pierre-Alain
    Schappler, Julie
    JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS, 2013, 74 : 205 - 212
12345